FDA Inspection
Lupin Ltd.Lupin Ltd. – FDA Inspection, Sep 5, 2025
Record Details
This FDA Inspection record concerns Lupin Ltd., with an inspection on September 5, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 0aec7ac9-3de1-4946-b768-6123a636ed4a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1280668
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
FDA Citations
2- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.67(c)Cleaning/maintenance records not kept
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lupin Ltd.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 15, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2019 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| July 28, 2017 | Not classified | Office of Inspections and Investigations | |
| April 26, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Lupin Ltd.
- FDA Inspection 1235550 - 2024-03-15
- FDA Inspection 1121188 - 2020-02-14
- FDA Inspection 1090546 - 2019-05-15
- FDA Inspection 1024531 - 2017-07-28
- FDA Inspection 1012780 - 2017-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.